KPC Pharmaceuticals, Inc. (600422.SS) SHH

12.66

+0.18(+1.44%)

Updated at December 25 02:56PM

Currency In CNY

Valuation

Market Cap11.94B
Enterprise Value10.43B
P/E Ratio18.07
PEG Ratio-1.33
Price/Sales Ratio1.24
Price/Book Ratio1.8
Enterprise/Revenue1.38
Enterprise/EBITDA13.47

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.07
Operating Margin0.09

Management Effectiveness

Return On Assets0.04
Return On Equity0.1

Income Statement

Revenue8.4B
Revenue/Share10.17
Gross Profit3.63B
EBITDA964.84M
Net Income648.08M
Diluted EPS0.86

Balance Sheet

Total Cash2.76B
Total Cash/Share3.65
Total Debt1.82B
Total Debt/Equity0.34
Current Ratio1.93
Book Value Per Share9.06

Price History

52-Week Change-23.93
52-Week High18.64
52-Week Low12.24
Moving Average 50 Days13.34
Moving Average 200 Days14.77

Statistics

Average Volume6.71M
Shares Outstanding756.98M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield2.37
Payout Ratio0.05
Last Split Factor2:1
Last Split DateMay 09, 2016